Newly released market study: Illumina, Inc. (ILMN) - Product Pipeline Analysis, 2015 Update

Illumina, Inc. (Illumina) is a molecular diagnostics company. It develops, manufactures and markets life science tools and integrated systems for genetic variation and function analysis. The company offers solutions for copy number variation, single nucleotide polymorphism genotyping, gene expression profiling of DNA and RNA, and deoxyribonucleic acid methylation studies. Illumina offers its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The products offered by Illumina for genomic analysis include HiSeq 2500, NextSeq 500, MiSeq, HiScanSQ systems. The core technologies of the company include Sequencing by Synthesis (SBS), BeadArray and Real-Time PCR technology. The company's products are distributed to various countries through its distributors in Europe, India, Israel, Korea, Malaysia, Greece, Turkey, Taiwan, Thailand, Vietnam, South Africa, Saudi Arabia, Russia, Ukraine, Belarus and other countries. Illumina is headquartered in San Diego, California, the US.
The company focuses on discover new opportunities and applications fueled by its next-generation sequencing. The this end the company recently in January 2015, the company expanded its next generation sequencing portfolio with the launch of HiSeq X five system, and HiSeq 3000/4000 systems.

Full Report Details at
- http://www.fastmr.com/prod/998562_illumina_ilmn_product.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Illumina, Inc.
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cepheid (CPHD) - Product Pipeline Analysis, 2015 Update
- Becton, Dickinson and Company (BDX) - Product Pipeline Analysis, 2015 Update
- EKF Diagnostics Holdings plc (EKF) - Product Pipeline Analysis, 2015 Update
- Roche Diagnostics International Ltd. - Product Pipeline Analysis, 2015 Update
- Genentech, Inc. - Product Pipeline Analysis, 2015 Update